Overview

* Crescita Q2 revenue rises 52.5% yr/yr, driven by manufacturing and Croma payment

* Net income reaches C$798k, reversing a loss from prior year

* Adjusted EBITDA improves significantly, reflecting operational efficiencies

Outlook

* Crescita exploring partnerships for Pliaglis in European markets

* Crescita regained Pliaglis rights in several territories after Croma termination

* Company actively seeking new partners for Pliaglis commercialization

Result Drivers

* MANUFACTURING VOLUMES - Revenue increase driven by ramp-up of production volumes with new customer in Manufacturing segment

* TERMINATION PAYMENT - CAD 900,000 added to revenue from mutual termination agreement with Croma

* SKINCARE GROWTH - Skincare segment sales rose due to Aquafolia acquisition and higher export sales

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 C$6.23

Revenue mln

Q2 C$964,00

Adjusted 0

EBITDA

Q2 Gross 61.4%

Margin

Q2 C$3.24

Operatin mln

g

Expenses

Q2 C$583,00

Operatin 0

g Income

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)